Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 121-130 of 150 for

Edit search filters
  1. Surveillance of Colorectal Dysplasia to Treat Inflammatory Bowel Disease with Wide Area Transepithelial Sample (WATS)

    Rochester, MN

  2. Infliximab Response in Inflammatory Bowel Disease

    Rochester, MN

  3. Collection of Blood in Patients with Inflammatory Bowel Disease

    Scottsdale/Phoenix, AZ

  4. Markers of Inflammatory Bowel Disease Severity

    Rochester, MN

  5. Study to Better Understand the Development of Irritable Bowel Disease (IBD) and Related Diseases as a Step Toward Improving Disease Outcomes.

    Rochester, MN

  6. SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry

    Rochester, MN

  7. A Study to Understand Crohn’s Disease using a Genetic Approach

    Rochester, MN

  8. Transforming Healthcare and Outcomes for Children with Inflammatory Bowel Disease

    La Crosse, WI, Eau Claire, WI, Mankato, MN, Rochester, MN

  9. Developing Novel Microbiota-Targeted Therapies for Irritable Bowel Syndrome

    Rochester, MN

  10. Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease

    Jacksonville, FL

.

Mayo Clinic Footer